Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.

Publication Title

J Immunother Cancer

Document Type

Article

Publication Date

4-1-2020

Keywords

Betacoronavirus; Coronavirus Infections; Drug Approval; Humans; Immunologic Factors; Immunotherapy; Inflammation; Interleukin-6; Neoplasms; Pandemics; Pneumonia, Viral; Receptors, Interleukin-6; 2019-nCoV

Clinical Institute

Cancer

Specialty

Oncology

Specialty

Infectious Diseases

Share

COinS